TABMELT® Granted Patent Rights in Russia, Expanding Vivera Global Licensing
NEWPORT BEACH, Calif., Feb. 25, 2021 /PRNewswire/ — Vivera Pharmaceuticals, Inc., is pleased to announce the expansion of its exclusive global licensing of the novel TABMELT® platform to Russia. The latest TABMELT® patent approval comes as the Company begins to expand its pharmaceutical offerings into neuroscience, and joins Canada, the United Kingdom, and Australia as […]
